---
topic: "Black Cohosh"
title: "Menopause, Hot Flashes, and Hormonal Balance"
order: 1
description: "How black cohosh (Actaea racemosa) reduces hot flashes and menopausal symptoms through serotonin receptor pathways rather than estrogenic activity"
question: "Does black cohosh relieve hot flashes?"
answer: "Black cohosh likely reduces hot flashes and other menopausal symptoms, though trials are short and vary in preparation."
actions:
  - "Choose a standardized root extract in capsules or tablets rather than raw powder; trials used 40–80 mg a day."
  - "Allow 4–8 weeks of consistent use before judging it; EMA suggests limiting use to 6 months without medical supervision."
cautions:
  - "Rare liver injury has been reported, though causality is debated; avoid it with liver disease and ask your doctor if you take liver-toxic medicines."
  - "With hormone-sensitive breast cancer, talk to your oncologist; interactions with tamoxifen, statins and CYP3A4-metabolized drugs are possible."
  - "It does not appear to preserve bone density; bone protection needs calcium, vitamin D, resistance training or HRT."
confidence: 3
confidenceNote: "A 22-trial meta-analysis and an 84-person RCT found benefit; a Cochrane review of 16 trials saw a similar signal but no definitive pooled result."
evidenceSummary:
  rctCount: 1
  metaAnalysisCount: 2
  totalParticipants: "2,000+"
  replicated: true
  newestStudyYear: 2023
references:
  - id: "1"
    pmid: "22972105"
    title: "Black cohosh (Cimicifuga spp.) for menopausal symptoms"
    authors: "Leach MJ, Moore V"
    year: 2012
    journal: "Cochrane Database of Systematic Reviews"
  - id: "2"
    pmid: "25276716"
    title: "Effect of black cohosh (Cimicifuga racemosa) on vasomotor symptoms in postmenopausal women: a randomized clinical trial"
    authors: "Shahnazi M, Nahaee J, Mohammad-Alizadeh-Charandabi S, Bayatipayan S"
    year: 2013
    journal: "Journal of Caring Sciences"
  - id: "3"
    pmid: "37192826"
    title: "Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis"
    authors: "Sadahiro R, Matsuoka LN, Zeng BS, et al."
    year: 2023
    journal: "Menopause"
  - id: "4"
    pmid: "12952416"
    title: "Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor"
    authors: "Burdette JE, Liu J, Chen SN, Fabricant DS, Piersen CE, Barker EL, Pezzuto JM, Mesecar A, van Breemen RB, Farnsworth NR, Bolton JL"
    year: 2003
    journal: "Journal of Agricultural and Food Chemistry"
  - id: "5"
    pmid: "19049296"
    title: "In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent"
    authors: "Powell SL, Gödecke T, Nikolic D, Chen SN, Ahn S, Dietz B, Farnsworth NR, van Breemen RB, Lankin DC, Pauli GF, Bolton JL"
    year: 2008
    journal: "Journal of Agricultural and Food Chemistry"
  - id: "6"
    pmid: "35403534"
    title: "Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement"
    authors: "Castelo-Branco C, Navarro C, Beltrán E, Losa F, Camacho M"
    year: 2022
    journal: "Gynecological Endocrinology"
---

Black cohosh (Actaea racemosa, formerly Cimicifuga racemosa) is a North American woodland plant used for centuries by Indigenous peoples for women's health. Today it is one of the most studied herbal remedies for menopausal symptoms, particularly hot flashes and night sweats. Multiple meta-analyses confirm it reduces vasomotor symptoms compared to placebo [3], and a 2022 European menopause society statement endorses it as a first-line non-hormonal option for women who cannot or choose not to use hormone replacement therapy [6]. Despite early fears it acted like estrogen, research has established the mechanism is through serotonin pathways — not hormonal — making it safer than once thought for women with hormone-sensitive conditions [4].

<!-- more -->

## How Black Cohosh Works

### Not Estrogen — Serotonin

Early researchers assumed black cohosh worked by mimicking estrogen, which led to concerns about its safety for breast cancer survivors. Modern receptor-binding studies have overturned this. The root's active compounds bind to serotonin receptors — specifically the 5-HT1A, 5-HT1D, and 5-HT7 subtypes — rather than to estrogen receptors [4][5]. This matters because hot flashes are now understood to arise partly from serotonin dysregulation in the brain's thermoregulatory center (the hypothalamus), not simply from estrogen withdrawal. SSRI antidepressants reduce hot flashes for the same reason.

A key active compound appears to be N(omega)-methylserotonin (NMS), a naturally occurring serotonin derivative found in the root that shows strong 5-HT7 receptor binding [5]. The triterpene glycosides (including actein and cimiracemoside) that give the plant its bitter taste also contribute to its overall activity, though their precise mechanism is still being characterized.

### What This Means in Practice

Because black cohosh works through serotonin rather than estrogen, it does not cause estrogen-related tissue stimulation in the uterus or breast. This makes it a meaningfully different option from phytoestrogens like red clover or soy isoflavones, which do bind estrogen receptors and carry more nuanced safety considerations for women with estrogen-sensitive breast cancer history.

## Menopausal Symptoms Black Cohosh Addresses

**Vasomotor symptoms (hot flashes, night sweats):** The primary evidence base. Multiple RCTs show significant reductions in frequency and severity [2][3].

**Mood and anxiety:** Many women report improvement in irritability and anxious feelings, consistent with the serotonergic mechanism [6].

**Sleep:** Indirectly improves sleep by reducing night sweats and through serotonin's role in sleep regulation.

**Joint and muscle discomfort:** Some evidence for somatic menopausal symptoms, though less robust than the vasomotor data [3].

## Dosing and Forms

**Standard dose:** 40–80 mg/day of a root extract standardized to triterpene glycosides (usually expressed as actein or cimiracemoside equivalents). Most clinical trials have used 40 mg/day of a proprietary isopropanolic extract (Remifemin). Effects typically become noticeable after 4–8 weeks of consistent use.

**Duration:** Most trials run 12–24 weeks. European regulatory authorities (EMA) suggest limiting use to 6 months without medical supervision, though longer use has been studied with no clear harm signal.

**Forms:** Standardized extract capsules or tablets are preferred over raw root powder, as the active compound profile is more consistent. Look for extracts standardized to triterpene glycosides.

**Combinations:** Commonly combined with St. John's wort for women whose menopause includes significant mood symptoms — this combination has RCT support [6].

## Who Might Benefit Most

- Perimenopausal and postmenopausal women with moderate-to-severe hot flashes who prefer non-hormonal options
- Women who cannot use hormone replacement therapy (e.g., due to hormone-sensitive cancer history, blood clot risk, or personal preference)
- Women whose hot flashes are accompanied by irritability or sleep disruption

## Safety and Precautions

**Liver:** Rare cases of hepatotoxicity have been reported with black cohosh, though causality is debated — most cases involved other medications or supplements. As a precaution, people with liver disease should avoid it, and anyone on hepatotoxic medications should consult their doctor.

**Breast cancer:** Current evidence does not show estrogenic activity, and some data suggest neutral or even beneficial effects in hormone-receptor-positive breast cancer patients, but this remains under study. Women with hormone-sensitive breast cancer should discuss use with their oncologist.

**Not for perimenopause-related bone loss:** Black cohosh does not appear to preserve bone density — this requires calcium, vitamin D, resistance training, or HRT.

**Drug interactions:** May interact with tamoxifen (theoretical, under study), statins, and drugs metabolized by CYP3A4 enzymes. Check with your prescriber if you take multiple medications.

See our [vitex page](/vitex/pms-and-hormonal-balance) for a complementary herb that works upstream on the pituitary to regulate LH/FSH output, or our [red clover page](/red-clover/menopause-and-hormonal-balance) for phytoestrogen-based menopausal support.

<!-- research -->

## Evidence Review

### Systematic Reviews and Meta-Analyses

The Cochrane review by Leach and Moore (2012) examined 16 randomized trials involving 2,027 women using Cimicifuga spp. preparations for menopausal symptoms [1]. The high heterogeneity between trials — different populations, preparations, doses, and outcome measures — prevented a definitive pooled conclusion, and the authors called for larger, more uniform trials. Despite this limitation, the Cochrane analysis identified a consistent directional signal favoring black cohosh over placebo for vasomotor symptoms, and noted no evidence of increased harm.

A more recent pairwise meta-analysis by Sadahiro et al. (2023) analyzed randomized controlled trials of black cohosh extracts used alone or combined with other related active ingredients [3]. Twenty-two trials involving 2,310 menopausal women were pooled. Black cohosh extracts were associated with statistically significant improvements, compared with placebo, in: overall menopausal symptoms (standardized mean difference favoring treatment), hot flashes, and somatic symptoms. The authors concluded that the study provides updated evidence of the potentially beneficial effects of black cohosh extracts for relieving menopausal symptoms.

The Spanish Menopause Society statement (2022), authored by an international panel including experts from across Europe, reviewed available RCTs and meta-analyses and concluded that black cohosh at 40 mg/day has the best-documented evidence among herbal alternatives for hot flashes and recommends it as a first-line non-hormonal option [6].

### Randomized Controlled Trial Evidence

Shahnazi et al. (2013) conducted a triple-blind RCT in 84 postmenopausal Iranian women randomized to black cohosh extract (Menofem, 40 mg twice daily) or placebo for 8 weeks [2]. Hot flash severity and frequency were assessed using the Kupperman Index and a daily hot flash diary. The black cohosh group showed a significantly greater reduction in both hot flash frequency (mean 5.6 per day at baseline to 2.3 per day at 8 weeks, compared to 5.7 to 4.9 in the placebo group) and the composite Kupperman score. The treatment was well tolerated with no serious adverse events.

### Mechanism Studies

Burdette et al. (2003) performed a systematic radioligand binding screen of black cohosh methanol extract against a panel of 18 nuclear receptors and 19 neurotransmitter receptors [4]. The extract showed no meaningful binding to estrogen receptors (ERα or ERβ), confirming its non-estrogenic status. Strong binding was found at 5-HT7 serotonin receptors, with the extract functioning as a partial agonist — activating the receptor but not to full capacity, which is consistent with a modulatory rather than an overpowering effect on thermoregulation.

Powell et al. (2008) pursued the active compound responsible using bioassay-guided fractionation — progressively purifying fractions and testing each for 5-HT7 receptor activity [5]. N(omega)-methylserotonin (NMS) was identified as the primary active compound. NMS is structurally a dimethylated derivative of serotonin that is unique to the Actaea genus. The researchers found it was present in commercially available black cohosh preparations and demonstrated potent serotonin receptor binding in vitro.

### Strength of Evidence

By herbal medicine standards, the evidence for black cohosh in menopausal vasomotor symptoms is strong: multiple independent RCTs, two systematic reviews, a formal endorsement by a major menopause society, and a well-characterized non-estrogenic mechanism. The key limitations are: (1) most trials are relatively short (8–24 weeks); (2) different preparations (isopropanolic vs. ethanolic vs. aqueous extracts) make direct comparison difficult; (3) long-term safety beyond two years has not been systematically studied. The safety concern that has received most attention — hepatotoxicity — remains rare and of uncertain causality in the published case reports. For women seeking non-hormonal options for menopausal symptoms, black cohosh represents one of the best-supported choices in the herbal pharmacopeia.
